Regulatory Basis
The disclosure is made pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Event Details
A group of analysts/investors is scheduled to visit the company's plant followed by a meeting with the management. The specifics are:
- Date: 10th June, 2026
- Attendees: Group of Investors
- Location: Bangalore
- Meeting Type: Plant Visit & Group Meeting
- Mode: Physical
Important Disclaimer
The company explicitly states that no unpublished price-sensitive information (UPSI) will be discussed during the meeting and/or plant visit. It also notes that any unforeseen exigency on the part of the Company or the Host may lead to a change in the date or time.
Additional Information
The intimation is also available on the Company's website at https://anthembio.com/investors/.
Company & Signatory
The filing is made by Anthem Biosciences Limited, which was formerly known as Anthem Biosciences Private Limited. It is signed by Divya Prasad, Company Secretary & Compliance Officer (Membership No: A41438), on June 05, 2026.